Results 1 to 10 of about 3,186 (156)

Notoginsenoside R1, a Metabolite from Panax notoginseng, Prevents Paclitaxel-Induced Peripheral Neuropathic Pain in Mice [PDF]

open access: yesMolecules
Development of paclitaxel-induced neuropathic pain (PINP) during chemotherapy may lead to paclitaxel discontinuation, potentially compromising effective anticancer therapy. PINP can manifest as allodynia.
Muneerah Al-Musailem   +2 more
doaj   +2 more sources

Correlation Between In Silico Docking/Simulation Results and In Vitro MAGL Inhibition Potency of Selected Triterpenes [PDF]

open access: yesCurrent Issues in Molecular Biology
Monoacylglycerol lipase (MAGL) degrades the endocannabinoid 2-arachidonyl glycerol. MAGL inhibitors, such as the triterpene pristimerin, alleviate neuropathic pain in animal models.
Willias Masocha, Mohammed A. Khedr
doaj   +2 more sources

MAGL-18c attenuates LPS-induced sepsis-associated liver injury by inhibiting TGF-β/Smad signaling and remodeling medium- and long-chain fatty acid metabolism [PDF]

open access: yesFrontiers in Immunology
IntroductionSepsis is a major global health burden associated with high mortality and multiple organ dysfunction, among which liver injury is a key determinant of poor prognosis.
Ying Wang   +14 more
doaj   +2 more sources

Enhancement of the endocannabinoid system through monoacylglycerol lipase inhibition relieves migraine-associated pain in mice [PDF]

open access: yesThe Journal of Headache and Pain
Background Migraine affects over 1 billion people worldwide and is a leading cause of disability. Targeting the cannabinoid system offers a promising approach for pain and migraine relief.
Elizaveta Mangutov   +5 more
doaj   +2 more sources

Discovery of MAGL Inhibition by Lophine Derivatives: An Unexpected Finding from Chemiluminescent Assay Development [PDF]

open access: yesMolecules
The inhibitory effects of two novel lophine derivatives were unexpectedly discovered during the development of a chemiluminescent monoacylglycerol lipase (MAGL) assay.
Roberta Ottria   +4 more
doaj   +2 more sources

MAGL targeted PROTAC degrader simultaneously enhances P53 for synergistic treatment of glioblastoma stem cell [PDF]

open access: yesCell Death Discovery
Glioblastoma (GBM) stands as the most fatal brain tumor due to limited therapeutic options and high rates of drug resistance. Current surgical and pharmacological interventions usually fail to eradicate the aggressive GBM stem cells (GSCs), which leads ...
Zheng Yuan   +10 more
doaj   +2 more sources

Inhibition of endocannabinoid hydrolases MAGL, FAAH and ABHD6 by AKU-005 reduces ex vivo cortical spreading depression [PDF]

open access: yesThe Journal of Headache and Pain
Background Migraine is a common neurovascular disorder that remains currently untreated in half of the patients. One third of migraine patients experience aura, which is associated with the development of cortical spreading depolarization (CSD), a wave ...
Flavia Brugia   +8 more
doaj   +2 more sources

[18F]MAGL-4-11 positron emission tomography molecular imaging of monoacylglycerol lipase changes in preclinical liver fibrosis models

open access: yesActa Pharmaceutica Sinica B, 2022
Monoacylglycerol lipase (MAGL) is a pivotal enzyme in the endocannabinoid system, which metabolizes 2-arachidonoylglycerol (2-AG) into the proinflammatory eicosanoid precursor arachidonic acid (AA).
Tuo Shao   +14 more
doaj   +1 more source

Pristimerin, a triterpene that inhibits monoacylglycerol lipase activity, prevents the development of paclitaxel-induced allodynia in mice

open access: yesFrontiers in Pharmacology, 2022
Background: Triterpenes such as euphol and pristimerin, which are plant secondary metabolites, were the first to be characterized as monoacylglycerol lipase (MAGL) inhibitors.
Altaf Al-Romaiyan, Willias Masocha
doaj   +1 more source

Development of a highly-specific 18F-labeled irreversible positron emission tomography tracer for monoacylglycerol lipase mapping

open access: yesActa Pharmaceutica Sinica B, 2021
As a serine hydrolase, monoacylglycerol lipase (MAGL) is principally responsible for the metabolism of 2-arachidonoylglycerol (2-AG) in the central nervous system (CNS), leading to the formation of arachidonic acid (AA).
Zhen Chen   +21 more
doaj   +1 more source

Home - About - Disclaimer - Privacy